share_log
Moomoo 24/7 ·  03/18 06:38

Virpax Pharmaceuticals SaidOn March 15, Got Letter From Nasdaq That Co Has Regained Compliance With Listing Rule 5550(A)(2)

Virpax Pharmicals表示,3月15日收到纳斯达克的来信,称该公司已恢复遵守上市规则5550(A)(2)

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发